Alan H. Wu, PhD

Phone: 415-206-3540
UCSF Box: SFGH
Email: Alan.Wu@ucsf.edu
UCSF Profile

Project Sponsor Location(s) Topics Start End
Targeted Testing for Toxic Chemicals in People Natural Resources Defense Council, Inc. United States Occupational and Environmental Disease
Evaluation of BD Vacutainer SST Ultra and Serum Ultra Blood Collection Tubes for Selected Therapeutic Drugs (Sample Collection) Becton, Dickinson, and Company United States Cardiovascular Disease, Drug and Diagnostics Development
Determination of the Biological Variability (BV) of the Hevylite (HL) Assays. Binding Site, Inc. United States Drug and Diagnostics Development
Evaluation of the Samsung LABGEO IVD-A20 CHF Test in a Point-Of-Care Setting Samsung Advanced Institute of Technology United States Drug and Diagnostics Development
Clinitek Novus Second Clinical Trial Protocol Siemens Healthcare Diagnostics United States Drug and Diagnostics Development
Preliminary evaluation of ReLIA Point-of-Care Analyzer for Cardiac Troponin ReLIA Diagnostics, Inc United States Drug and Diagnostics Development
12-10542, Genetic Disease Laboratory and Genetic Disease Screening Program on Clinical Laboratory Improvement Amendments (CLIA) California Department of Public Health United States Health Systems Strengthening
Evaluation of the Samsung LABGEO IVD-A20 CHF Test in a Point-of-Care Setting Nexus Dx, Inc United States Drug and Diagnostics Development
Genetic Disease Laboratory and Genetic Disease Screening Program on Clinical Laboratory Improvement Amendments (CLIA) 15-10151 California Department of Public Health United States Genetics
Intraosseous Sampling for Postmortem Drugs and Alcohol Testing From a Medical Examiner's Office Vidacare Corporation United States Substance Abuse